Le Lézard
Classified in: Health
Subject: PDT

R3 Stem Cell Now Offering Effective Treatment for Trigeminal Neuralgia


LAS VEGAS, July 16, 2018 /PRNewswire-PRWeb/ -- R3 Stem Cell is now offering effective treatment for trigeminal neuralgia at its Center of Excellence in Las Vegas. The therapies are administered by highly skilled providers in a Concierge location.

Trigeminal neuralgia may be a debilitating condition for patients, with symptoms that can vary from sharp, stabbing pain to a constant aching or burning. Unfortunately the condition may be chronic and not respond well to traditional treatments.

When it comes to stem cell therapy for trigeminal neuralgia, several studies are showing excellent results with the procedures for neurologic conditions. The doctors in Las Vegas who administer the procedures are Double Board Certified and the Center is contemporary and accommodating for patients.

R3 Stem Cell currently offers a complimentary phone consultation for those interested in the procedure who do not live nearby. In addition, the R3 concierge service provides a dedicated patient representative to obtain medical records and assist with the logistics for travel.

With over ten thousand successful procedures performed nationwide, R3 is at the forefront of regenerative therapies. Patients come to the Centers from all over the country, as well as internationally. Visit the R3 concierge website to read more and call (844) GET-STEM to set up the free phone consultation.

SOURCE R3 Stem Cell


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: